New GLP-1 RA ‘better than semaglutide’ for weight loss in Lancet study
A high dose of a new once-weekly injected GLP-1 receptor agonist has outdone semaglutide for weight loss in a phase III trial. Ecnoglutide, developed in…
Tag: Bariatric
Bariatric surgeons under pressure? Life beyond the $69,000 premiums
Are bariatric surgeons in trouble? Many are facing sky-high premiums fuelled by an apparent rise in patient complaints. And what about the GLP-1s? Will they…
Bariatric surgery benefits teens with severe obesity for up to 10 years: research
Adolescents undergoing gastric bypass or sleeve gastrectomy for obesity have durable reductions in BMI and type 2 diabetes, according to findings from the longest follow-up…
Is semaglutide prescribing the reason bariatric surgeries are down?
Bariatric surgery numbers have fallen to their lowest level since 2016, with doctors saying the drop could reflect the use of non-surgical options like semaglutide…
Novo Nordisk finally launches semaglutide pen indicated for weight loss in Australia
Novo Nordisk’s subcutaneous weight-loss drug Wegovy will hit Australian shelves this month, two years after it received TGA approval. The once-weekly injectable semaglutide formulation will…
Abdominal fat rather than BMI alone ‘key to diagnosing obesity’
Patients with a BMI of ≥25kg/m2, a waist-to-height ratio of ≥0.5 and any medical complications should be diagnosed with obesity, according to a new clinical…
Lower BMI threshold for obesity needed in over-40s, say researchers
A lower BMI threshold of ≥27kg/m² may better identify obesity in patients over 40 than the accepted cut-off of ≥30kg/m², Italian researchers have argued at…
The $100m telehealth corporate prescribing compounded semaglutide — its top GP speaks with AusDoc
Telehealth corporate Eucalyptus is making headlines for prescribing off-label compounded semaglutide as part of an online weight loss program that costs up to $599 a…
Watch for poor bone health in teens after bariatric surgery, doctors say
Roux-en-Y gastric bypass and sleeve gastrectomy are “highly effective” and safe in under-18s with class II or III obesity but can lead to poorer bone…
Gastric bypass tied to substance use disorder
Gastric bypass surgery is associated with an increased risk for non-alcohol substance use disorder, according to a study in Obesity. Dr Per-Arne Svensson (PhD), from…
